Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas

Detalhes bibliográficos
Ano de defesa: 2007
Autor(a) principal: Andreia Maria Molica
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Minas Gerais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://hdl.handle.net/1843/ECJS-7F2H4S
Resumo: It has been demonstrated that cells from innate immune response secreted prostaglandins that act as regulators of the immune response against some infectious agents as the pathogen of Chagas disease, the Trypanosoma cruzi. In this work we evaluated the onocytes/macrophages activity as regulatory cells, by the production of PGE2 and cytokines, and as antigen presenting cells (APC) in non infected individuals (NI) and patients with the indeterminate(IND) or cardiac (CARD) clinical forms of Chagas disease. We isolated peripheral blood mononuclear cells (total and not adherent) and performed cellular proliferative assays in the presence or not of T. cruzi antigens. After eighteen hours of culture, the supernatants were assayed for the presence of PGE2, IL-2, IL-4, IL-10 and IFN-g. Expression of CD14, CD19, HLA-DR, CD80 and CD86 markers were performed in the culture cells. Our data showed a high proliferative response of IND and CARD patients when compared to the NI group, in the presence of antigen. After removal of the adherentcells we observed an increase in the proliferative response of cells from the NI group. In the presence of Indomethacin, a PGE2 blocker, we observed that the proliferative response of cells from IND patients could be subdivided into high (AR) and down (BR) responders. These results demonstrate that the PGE2 inhibition influences the cellularproliferate response of IND patients. It interesting to note, that IND and CARDpatients presented similar levels of PGE2 in comparison to NI group. These data evidence that PGE2 has an important role as an immune regulatory molecule. Our results also showed higher levels of IL-2, IL-4, IL-10 e IFN-g cytokines in antigen stimulated cultures when comparied to non the stimulated. Phenotypical analyses of PBMC and NA populations demonstrated that CD14+ cells have similar expression of HLA-DR, CD80 and CD86 in cultures stimulated or not with T. cruzi antigen. IND patients cells presented lower HLA-DR and CD80 expression although not significant. Analyses of CD19+ cells in NA stimulated cultures showed higher expression of HLA-DR and CD80 molecules when compared with non stimulated cultures. These results demonstrated that in the absence of macrophages, B-lymphocytes may function as antigen presenting cells. These data suggest that in presence of T. cruzi, APC function of B-lymphocytes is regulated by macrophages, independent of the secondary response, since NI cells presented the same phenotypical profile by the patients with Chagas disease.
id UFMG_d7ef48dbbf5253d690701d130c0f293a
oai_identifier_str oai:repositorio.ufmg.br:1843/ECJS-7F2H4S
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling 2019-08-11T17:42:26Z2025-09-08T23:13:23Z2019-08-11T17:42:26Z2007-07-12https://hdl.handle.net/1843/ECJS-7F2H4SIt has been demonstrated that cells from innate immune response secreted prostaglandins that act as regulators of the immune response against some infectious agents as the pathogen of Chagas disease, the Trypanosoma cruzi. In this work we evaluated the onocytes/macrophages activity as regulatory cells, by the production of PGE2 and cytokines, and as antigen presenting cells (APC) in non infected individuals (NI) and patients with the indeterminate(IND) or cardiac (CARD) clinical forms of Chagas disease. We isolated peripheral blood mononuclear cells (total and not adherent) and performed cellular proliferative assays in the presence or not of T. cruzi antigens. After eighteen hours of culture, the supernatants were assayed for the presence of PGE2, IL-2, IL-4, IL-10 and IFN-g. Expression of CD14, CD19, HLA-DR, CD80 and CD86 markers were performed in the culture cells. Our data showed a high proliferative response of IND and CARD patients when compared to the NI group, in the presence of antigen. After removal of the adherentcells we observed an increase in the proliferative response of cells from the NI group. In the presence of Indomethacin, a PGE2 blocker, we observed that the proliferative response of cells from IND patients could be subdivided into high (AR) and down (BR) responders. These results demonstrate that the PGE2 inhibition influences the cellularproliferate response of IND patients. It interesting to note, that IND and CARDpatients presented similar levels of PGE2 in comparison to NI group. These data evidence that PGE2 has an important role as an immune regulatory molecule. Our results also showed higher levels of IL-2, IL-4, IL-10 e IFN-g cytokines in antigen stimulated cultures when comparied to non the stimulated. Phenotypical analyses of PBMC and NA populations demonstrated that CD14+ cells have similar expression of HLA-DR, CD80 and CD86 in cultures stimulated or not with T. cruzi antigen. IND patients cells presented lower HLA-DR and CD80 expression although not significant. Analyses of CD19+ cells in NA stimulated cultures showed higher expression of HLA-DR and CD80 molecules when compared with non stimulated cultures. These results demonstrated that in the absence of macrophages, B-lymphocytes may function as antigen presenting cells. These data suggest that in presence of T. cruzi, APC function of B-lymphocytes is regulated by macrophages, independent of the secondary response, since NI cells presented the same phenotypical profile by the patients with Chagas disease.Universidade Federal de Minas GeraisResposta imuneMacrófagosAPCLinfócito BTrypanosoma cruziMedicina TropicalLinfócitos BMacrófagos/imunologiaSistema imuneDoença de Chagas/imunologiaTrypanosoma cruzi/imunologiaIn vitroAssociação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisAndreia Maria Molicainfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGManoel Otavio da Costa RochaJuliana de Assis Gomes EstanislauMaria José Ferreira MoratoAndré TalvaniSilvana Maria Eloi SantosTrabalhos anteriores mostraram que células da imunidade inata produzem prostaglandinas que atuam como moléculas reguladoras da resposta imune a vários agentes etiológicos, incluindo o Trypanosoma cruzi, causador da doença de Chagas. O objetivo do presente trabalho foi avaliar o papel de monócitos/macrófagos como célula reguladora, através da produção de PGE2 e de citocinas, bem como o de célula apresentadora de antígeno em indivíduos não infectados (NI) e portadores da doença de Chagas, com as formas clínicas indeterminada ou cardíaca. Células mononucleares totais (PBMC) e não aderentes (NA) do sangue periférico foram isoladas. Parte destas células foi submetida ao ensaio de proliferação celular, durante seis dias, na presença e ausência de antígenos do T. cruzi, a outra parte foi cultivada durante dezoito horas, após este período coletou-seo sobrenadante para dosagem de PGE2 e de IL-2, IL-4, IL-10 e IFN-g . As células foram utilizadas para análise fenotípica dos marcadores CD14, CD19, HLADR, CD80 e CD86. A resposta proliferativa a antígenos do T cruzi mostrou-se aumentada nos indivíduos dos grupos IND e CARD quando comparados ao grupo NI. Porém após remoção das células aderentes houve aumento da resposta proliferativa nos indivíduos NI. A adição de bloqueador (indometacina) de PGE2 as culturas de PBMC evidencia a formação de dois subgrupos dentro do grupo IND: altos respondedores (AR) e baixos respondedores (BR), mostrando que o bloqueio de PGE2 pode influenciar a resposta proliferativa nos indivíduos do grupo IND. A dosagem de PGE2 apresentou níveis semelhantes entre os grupos IND e CARD quando comparados ao grupo NI sugerindo um papel de molécula reguladora de PGE2 na tentativa de retorno a homeostasia do sistema imune. Por outro lado a dosagem das citocinas IL- 2, IL-4, IL-10 e IFN-g, mostraram níveis aumentados em quase todas as culturas estimuladas quando comparada as culturas sem estímulo. O estudo do fenótipo de células mononucleares totais e células não aderentes mostraram que células CD14+ expressam moléculas HLA-DR, CD80 e CD86 com intensidade semelhante nas culturas estimuladas ou não com T. cruzi, porém,apesar de não haver significância, é possível observar no grupo IND uma expressão menor de moléculas HLA-DR e CD 80. Já as células CD19+ expressam moléculas HLA-DR e CD80 com intensidade significativamente maior nas culturas NA estimuladas quando comparadas às culturas sem estímulo. Demonstrando quelinfócitos B em culturas empobrecidas de macrófagos intensificam sua função de APC. Os dados em conjunto sugerem que linfócitos B têm sua função de APC regulada por macrófagos frente estimulação antigênica pelo T. cruzi independente da resposta secundária, uma vez que células de indivíduos NI apresentam o mesmo perfil fenotípico dos pacientes estudados.UFMGORIGINALandreia__maria_molica.pdfapplication/pdf886005https://repositorio.ufmg.br//bitstreams/60e4ff01-2b4a-4f12-9ff6-1bc1d3442df4/downloadce63d9d557751bcd1aa9558d42cd39dbMD51trueAnonymousREADTEXTandreia__maria_molica.pdf.txttext/plain157236https://repositorio.ufmg.br//bitstreams/0f2e681a-d515-4bed-ad8d-109c7fd5cecb/downloadbfd0943b57cdac97d53a154e531e2f61MD52falseAnonymousREAD1843/ECJS-7F2H4S2025-09-08 20:13:23.207open.accessoai:repositorio.ufmg.br:1843/ECJS-7F2H4Shttps://repositorio.ufmg.br/Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2025-09-08T23:13:23Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
title Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
spellingShingle Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
Andreia Maria Molica
Medicina Tropical
Linfócitos B
Macrófagos/imunologia
Sistema imune
Doença de Chagas/imunologia
Trypanosoma cruzi/imunologia
In vitro
Resposta imune
Macrófagos
APC
Linfócito B
Trypanosoma cruzi
title_short Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
title_full Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
title_fullStr Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
title_full_unstemmed Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
title_sort Associação entre apresentação de antígeno, imunorregulação e morbidade na doença de Chagas
author Andreia Maria Molica
author_facet Andreia Maria Molica
author_role author
dc.contributor.author.fl_str_mv Andreia Maria Molica
dc.subject.por.fl_str_mv Medicina Tropical
Linfócitos B
Macrófagos/imunologia
Sistema imune
Doença de Chagas/imunologia
Trypanosoma cruzi/imunologia
In vitro
topic Medicina Tropical
Linfócitos B
Macrófagos/imunologia
Sistema imune
Doença de Chagas/imunologia
Trypanosoma cruzi/imunologia
In vitro
Resposta imune
Macrófagos
APC
Linfócito B
Trypanosoma cruzi
dc.subject.other.none.fl_str_mv Resposta imune
Macrófagos
APC
Linfócito B
Trypanosoma cruzi
description It has been demonstrated that cells from innate immune response secreted prostaglandins that act as regulators of the immune response against some infectious agents as the pathogen of Chagas disease, the Trypanosoma cruzi. In this work we evaluated the onocytes/macrophages activity as regulatory cells, by the production of PGE2 and cytokines, and as antigen presenting cells (APC) in non infected individuals (NI) and patients with the indeterminate(IND) or cardiac (CARD) clinical forms of Chagas disease. We isolated peripheral blood mononuclear cells (total and not adherent) and performed cellular proliferative assays in the presence or not of T. cruzi antigens. After eighteen hours of culture, the supernatants were assayed for the presence of PGE2, IL-2, IL-4, IL-10 and IFN-g. Expression of CD14, CD19, HLA-DR, CD80 and CD86 markers were performed in the culture cells. Our data showed a high proliferative response of IND and CARD patients when compared to the NI group, in the presence of antigen. After removal of the adherentcells we observed an increase in the proliferative response of cells from the NI group. In the presence of Indomethacin, a PGE2 blocker, we observed that the proliferative response of cells from IND patients could be subdivided into high (AR) and down (BR) responders. These results demonstrate that the PGE2 inhibition influences the cellularproliferate response of IND patients. It interesting to note, that IND and CARDpatients presented similar levels of PGE2 in comparison to NI group. These data evidence that PGE2 has an important role as an immune regulatory molecule. Our results also showed higher levels of IL-2, IL-4, IL-10 e IFN-g cytokines in antigen stimulated cultures when comparied to non the stimulated. Phenotypical analyses of PBMC and NA populations demonstrated that CD14+ cells have similar expression of HLA-DR, CD80 and CD86 in cultures stimulated or not with T. cruzi antigen. IND patients cells presented lower HLA-DR and CD80 expression although not significant. Analyses of CD19+ cells in NA stimulated cultures showed higher expression of HLA-DR and CD80 molecules when compared with non stimulated cultures. These results demonstrated that in the absence of macrophages, B-lymphocytes may function as antigen presenting cells. These data suggest that in presence of T. cruzi, APC function of B-lymphocytes is regulated by macrophages, independent of the secondary response, since NI cells presented the same phenotypical profile by the patients with Chagas disease.
publishDate 2007
dc.date.issued.fl_str_mv 2007-07-12
dc.date.accessioned.fl_str_mv 2019-08-11T17:42:26Z
2025-09-08T23:13:23Z
dc.date.available.fl_str_mv 2019-08-11T17:42:26Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1843/ECJS-7F2H4S
url https://hdl.handle.net/1843/ECJS-7F2H4S
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
bitstream.url.fl_str_mv https://repositorio.ufmg.br//bitstreams/60e4ff01-2b4a-4f12-9ff6-1bc1d3442df4/download
https://repositorio.ufmg.br//bitstreams/0f2e681a-d515-4bed-ad8d-109c7fd5cecb/download
bitstream.checksum.fl_str_mv ce63d9d557751bcd1aa9558d42cd39db
bfd0943b57cdac97d53a154e531e2f61
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1862106014070865920